Our Feature Articles are pieces written to cover different angles of the company whether it be the personal side of a company or highlighting a company’s products or services and the industry they call home. Unlike straight news stories announcements… these articles help investors get closer to the companies they invest in and learn a side of the company that isn’t strictly related to a news event. To read any of our Feature Articles on this page, click the link below the picture, or just click on the picture above the Headline.
Feature News Story: Plandai Biotechnology’s ι Cannabis Extracts Destined for Network and Cable News
Feature News Story: Investors Confidently Back Nuvilex Acquisition of Diabetes Technology
Feature News Story: LifeApps Digital Media ι Should Benefit from Huge Growth in Mobile Commerce
Feature News Story: New Study Continues to Validate Nuvilex’s Approach to Medical Marijuana Research
Feature News Story: FDA Approves ABRAXANE for Pancreatic Cancer, Could Nuvilex’s Treatment Be Next
Feature News Story: Plandai Biotechnology, Inc. ι Phytofare™ Could Address Growing Diabetes Numbers
Feature News Story: Nuvilex, Inc. ι Investing Big in What Could Be Its Billion Dollar Future
Feature News Story: INSCOR, Inc.’s ι CEO Generating Explosive Revenues with New Contract
Feature News Story: Nuvilex, Inc. ι Strengthens its Hand in the Cancer Arena with Purchase of Assets
Feature News Story: Nuvilex, Inc. ι Acquisition Could be Steal of the Century and Worth Billions
Feature News Story: Nuvilex, Inc. ι a Biotech Developing Treatments for Healthcare’s Hard Targets
Feature News Story: INSCOR, Inc. ι Plan Helps Professional Athletes and Entertainers Build Wealth
Feature News Story: Plandai, Biotechnology, Inc. ι is Taking on the Malaria Parasite and Winning
Feature News Story: Nuvilex, Inc. ι Medical Marijuana Research May Enhance Its Diabetes Studies
Feature News Story: Nuvilex, Inc. & Celgene Corp. ι Can Both Replace Eli Lilly’s Cancer Drug, Gemzar
Feature News Story: Nuvilex, Inc. ι Cell Encapsulation Could Mimic Combination Chemotherapy
Feature News Story: Nuvilex, Inc. ι Price Valuation Justifies Investor Confidence in Biotech
Feature News Story: Human Clinical Trials Using Medical Marijuana Could Be Close in the U.S.
Feature News Story: Nuvilex, Inc. ι Can Benefit from Passage of This Week’s Medical Marijuana Bill
Feature News Story: Nuvilex, Inc. ι Expects its Technology Can Start to Change Life for Diabetics
Feature News Story: LifeApps Digital Media, Inc. ι is on the Right Side of Growing Trend
Feature News Story: Timing is Right for Big Pharma to Add Nuvilex, Inc. Technology to its Pipeline
Feature News Story: Nuvilex, Inc. ι Another Biotech Changing the Face of Medical Marijuana
Feature News Story: Nuvilex, Inc. ι Cell-in-a-Box Technology Could Revitalize Stem Cell Phenomenon
Feature News Story: Nuvilex, Inc. ι Finding the Green is in the Science
Feature News Story: Action Products ι Taps American Hero as Chairman
Feature News Story: Baristas Coffee Company ι Not Just Selling A Cup O’ Joe
Disclaimer: These articles are the opinion of Stock Market Media Group and were written based upon publicly available information. The Companies that are featured in the articles or non-affiliated third parties compensate Stock Market Media Group for the articles. Stock Market Media Group receives up to six hundred and fifty dollars per article. These articles are not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
The stem cell industry lost one of its key players earlier this month when industry pioneer, Geron Corporation announced its intention to exit the stem cell research market.
It’s that time again. Black Friday has arrived again, and with it the crowds of shoppers, the big promotions, and the analysts who fret that the next several weeks will make or break the year for retailers.
The South Korean Parliament just approved a free trade agreement with the United States. According to an article in The Wall Street Journal, agricultural exports from the US to South Korea will rise.
If you plan on trading penny stocks, it would be a good idea to have a good understanding of how the middle tier of the over-the-counter (OTC) market works – the OTCQB market.
Recent News Posts
Plandaí Biotechnology’s Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial
Written by ι Stock Market Media Group Staff — September 10, 2014
Plandaí Biotechnology (OTCQB: PLPL) recent…
SILVER SPRING, Md., Aug. 20, 2014 — Nuvilex, Inc. (NVLX), a clinical-stage, international biotechnology company pr…
Written by ι Stock Market Media Group Staff — July 7, 2014
Nuvilex, Inc. (OTCQB: NVLX) announced last week …
Written by ι Stock Market Media Group Staff — June 2, 2014
ForeverGreen Worldwide Corp. (OTCQB: FVRG) recen…